OrbiMed Advisors raises $550M for health venture fund
OrbiMed Advisors, which has invested in Ohio companies Athersys Inc. and ViewRay, has raised $550 million for its latest health venture capital fund.
OrbiMed Advisors, which has invested in Ohio companies Athersys Inc. and ViewRay, has raised $550 million for its latest health venture capital fund.
Could a new investment company made of veterans from MPM Capital, OrbiMed Advisors, Pfizer Inc. and Morgan Stanley signal a shift in philosophy for life-science venture firms?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.